Laurie Klabi, MD
Gynecology · Saint Louis, MONPI 1326074907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $273 and has fallen 63.6% since, to $99 in 2025. That places this record below the midpoint for gynecology clinicians in MO, where the typical reported total is $923.
Across 48 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$142
- Astellas Pharma US Inc$142
- Organon$125
- Evofem Biosciences, Inc.$98
- Exeltis, USA Inc.$90
- Merck$79
- plus $193 from 7 others
What the payments were for
- Food & beverage$85398%
- Education$162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $142 |
| Astellas Pharma US Inc | 7 | $142 |
| Organon | 6 | $125 |
| Evofem Biosciences, Inc. | 5 | $98 |
| Exeltis, USA Inc. | 6 | $90 |
| Merck | 4 | $79 |
| Lupin Inc. | 4 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Duchesnay USA Incorporated | 2 | $32 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$869 in reported general payments places this provider in the 45th percentile of 38 gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $2,601 |
| ValacyclovirValacyclovir Hcl | 11 | $395 |
| Medroxyprogesterone Acetate | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Saint Louis
- Corey WagnerSaint Louis$272K
- David LevineSaint Louis$201K
- Richard GimpelsonSaint Louis$28K
- Whitney RossSaint Louis$22K
- Jeffrey PeipertSaint Louis$22K
- David EisenbergSaint Louis$11K
- Kristie LouSaint Louis$6K
- Scott BiestSaint Louis$3K
- Patrick YeungSaint Louis$2K
- Rachel KmetzSaint Louis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.